A detailed history of Creative Planning transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Creative Planning holds 32,409 shares of PACB stock, worth $63,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,409
Previous 24,780 30.79%
Holding current value
$63,197
Previous $33,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$1.2 - $2.17 $9,154 - $16,554
7,629 Added 30.79%
32,409 $55,000
Q2 2024

Aug 15, 2024

BUY
$1.36 - $3.65 $33,700 - $90,447
24,780 New
24,780 $33,000
Q3 2023

Nov 16, 2023

BUY
$8.23 - $13.93 $1,646 - $2,786
200 New
200 $1,000
Q2 2021

Aug 04, 2021

SELL
$22.3 - $36.02 $232,455 - $375,472
-10,424 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$26.38 - $51.15 $274,985 - $533,187
10,424 New
10,424 $347,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.